These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10604177)

  • 21. Antiphospholipid antibodies, antiphospholipid syndrome and infections.
    Sène D; Piette JC; Cacoub P
    Autoimmun Rev; 2008 Feb; 7(4):272-7. PubMed ID: 18295729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does serum alpha interferon measurement aid in the etiological diagnosis of febrile adult patients?
    Juillien G; Haroche J; Bonnet P; Rozenberg F; Riou B; Hausfater P
    J Med Virol; 2007 Jul; 79(7):935-8. PubMed ID: 17516539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200.
    Lidar M; Lipschitz N; Langevitz P; Barzilai O; Ram M; Porat-Katz BS; Pagnoux C; Guilpain P; Sinico RA; Radice A; Bizzaro N; Damoiseaux J; Tervaert JW; Martin J; Guillevin L; Bombardieri S; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():649-57. PubMed ID: 19758211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoonoses: a personal perspective on the Jennerian principle of cross-protective immunity.
    Nelson GS
    J Med Microbiol; 1997 Jan; 46(1):6-11, 28-33. PubMed ID: 9003736
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lymphokines in the host defense against infection].
    Kasakura S
    Rinsho Byori; 1986 Jan; 34(1):11-6. PubMed ID: 3702074
    [No Abstract]   [Full Text] [Related]  

  • 26. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key.
    Christensen JE; Thomsen AR
    APMIS; 2009 May; 117(5-6):338-55. PubMed ID: 19400861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological disease mechanisms in acute and chronic infections].
    Frøland SS
    Tidsskr Nor Laegeforen; 1983 Jan; 103(3):184-6. PubMed ID: 6845312
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immune response to viral infection].
    Takahashi H
    Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2875-83. PubMed ID: 1438862
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of T cells in defense against infection].
    Revillard JP
    Rev Prat; 1988 Dec; 38(29):2152-6. PubMed ID: 3146805
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of interferon mediated anti-viral resistance.
    Clarke CJ; Trapani JA; Johnstone RW
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):117-30. PubMed ID: 12476793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural antibodies and complement link innate and acquired immunity.
    Ochsenbein AF; Zinkernagel RM
    Immunol Today; 2000 Dec; 21(12):624-30. PubMed ID: 11114423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of sex on immunity and resistance to bacterial and viral infections].
    Buschmann H
    Berl Munch Tierarztl Wochenschr; 1974 May; 87(10):194-6. PubMed ID: 4832194
    [No Abstract]   [Full Text] [Related]  

  • 33. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunotherapy with yolk antibodies to prevent infections in humans and animals.
    Larsson A; Carlander D
    Ups J Med Sci; 2003; 108(2):129-40. PubMed ID: 14649324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative information value of humoral immunity characteristics in some bacterial and viral infections].
    Saidova BM; Kishov MG; Akhmedov DR
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):50-4. PubMed ID: 12886632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward general prophylactic cancer vaccination.
    Hobohm U
    Bioessays; 2009 Oct; 31(10):1071-9. PubMed ID: 19708019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infection and blastic transformation].
    Saito H
    Rinsho Ketsueki; 1973 Apr; 14(4):470-4. PubMed ID: 4737749
    [No Abstract]   [Full Text] [Related]  

  • 38. [The pathomorphological aspects of arteriopathies associated with viral and microbial infections].
    Petica M; Athanasiu P; Dumitrescu SM; Petrescu A
    Rev Roum Virol; 1993; 44(1-2):61-7. PubMed ID: 8043479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infectious complications in the endangered host patient].
    Leibowitz RE
    Rev Enferm; 1981 Aug; 4 Suppl(38):10, 12-14. PubMed ID: 6914790
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunity to infection. Infection in primary immunodeficiency].
    Bernatowska E
    Przegl Epidemiol; 2001; 55 Suppl 3():68-75. PubMed ID: 11984963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.